We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Cheers Demon_G, I hadn't seen that.
The Company will hold a conference call for sell-side analysts and investors at 11:00 Thursday 22nd of October. Details for the conference call can be found at: https://www.speakservecloud.com/register-for-call/ecd1cd54-503e-4be0-8f00-3d0a0f92b6a1
Has CF announced a new interview this week? I've got down Proactive on Thursday next week, 29th.
Should have added this could mean recurring work for OO for a long long time as previous post...
Let's face it, Covid 19 will in reality become Covid 20, 21, 22, 23, 24, 25, 26, 27............59..as the virus mutates like the Flu and Cold viruses' this is what I take from this article...?
https://news.sky.com/story/coronavirus-first-vaccines-unlikely-to-end-pandemic-says-uk-vaccines-chief-12103362
This Thursday 22nd
Couldn't agree more DG...
Been in here since 11p, assumed it would get to c. 30p in 6-12 months. My main interest was challenge studies, but limited capacity (While benefit of Prep and Imutex would be one hit wonders). My view on that has changed completely in the last couple of weeks, and the news today re US and Australia was fab...
Scope for long term, recurring revenue growth...which is what will lift the share price.
The number of Covid strains plus mixed efficacy and the value of finding a winning formula, pharma will be running trials for years and if we can do this beyond a 24 bed unit in Whitechapel...happy days.
In here for the long term...
Is that next Thursday?
Demon when I said priced in I was only thinking about confirmation of the contract but the deal was much more than that like the value,the connections,the validation,the kudus,the publicity etc
I’m not sure it was all priced in, we will soon find out I guess. SP always seems to go south on news with the “sell on news” brigade. Funny thing now IMO is, I feel the company is more undervalued now than when it was sitting at 14p. Strange old world. GLA
Can anyone confirm if there were any chunky buys after hours around 17-15? Ta.
Why do some get so concerned when there’s a seller (s) after a 30% rise.
It’s guaranteed because their timeline is different to long term holders.
Is a universal Flu vaccine ( synthetic) really going to worthless in the light of now?
This is THE share in the light of now. All imo of course - we have never faced this since - ever- cause we’re connected - carpe or hide -
I know DG,
Today was not just about the contract being signed as that was all that may have been priced in.
We got the 3 booked challenge studies that was not known.Plus the reference to HC operations in Australia and US.
All the great publicity and support by real decision makers and the extent of the partnership speaks volumes
It’s all great news Ivy. A little bit of selling is good for the health of the SP. If it does dip again then it provides a great opportunity to buy. It’ll be interesting to hear what CF has got to say on Thursday, so much going on he’ll no doubt have something up his sleeve. The luckiest deal he ever done and will ever likely to do he said - he’s not wrong! Loads more to come here.
We've seen this pattern a few times recently, where good news has been greeted with a short period of negative price movement, followed by people finally digesting/understanding what the value of the announcements are in the following days (and consequent upwards movement).
Not that anyone bank on trying to predict the future when it comes to short-term SP movements, especially on AIM...
Bad day regarding the SP reaction to the news but we have seen it all before on AIM.
Question is does today’s news encourage you to buy more or sell.
Overwhelmingly for me it is a good day as it was confirmation of what we all expected bit you dint always get what you expect.
So CF has delivered again with probably £40 worth of bus.A UK govt contract which does nit come much better.Plus making unique facilities available at no cost.
Three slots already booked probably one for Imperial Vax.You do not get better backing and look who has supported it all the top names.
Look at the publicity absolutely overwhelming.
Do we think other commercial Companys will come on board.Well considering the U.K. is the worlds first to use HC trials any Vax or treatment Supplier in the works will be forming a queue.
Also these Vax will be around for a long time as 2nd generation ones will seek USPS so testing in sub populations/T Cell responses etc
Plus 90% of ORPH is non Covid so expect more contracts.
Plus Immutex and Genome data base cash dividends.
CF is tied in for a long time so will be playing long time unless of course we get a buy out.
GL with those that trade this but I really think the SP will be much higher at end of the plus the 2 cash events.
So a good day for me as I am happy to wait.